Hepatocyte and lipoprotein membrane lipids involved in VLDL assembly

Hepatocyte and lipoprotein membrane lipids involved in VLDL assembly refers to the collective group of lipid species—primarily triglycerides, phospholipids (such as phosphatidylcholine), and cholesterol esters—that are integrated into Very Low-Density Lipoprotein (VLDL) particles within the liver (Tiwari & Siddiqi, 2012, Gene). This assembly process occurs in the lumen of the endoplasmic reticulum and is strictly dependent on the activity of the microsomal triglyceride transfer protein (MTP) and the presence of apolipoprotein B-100 (Hussain et al., 2003, J Lipid Res). These lipids serve as the structural and functional core of the lipoprotein, enabling the transport of endogenous fats from the liver to peripheral tissues for energy use or storage. While these lipids are central to human lipid metabolism, they are generally classified as substrates or structural components rather than direct therapeutic targets. Pharmacological interventions, such as MTP inhibitors (e.g., lomitapide) or antisense oligonucleotides against ApoB (e.g., mipomersen), target the protein machinery responsible for lipid loading and particle secretion rather than the lipids themselves (Hegele et al., 2013, Lancet). Dysregulation of the assembly process, often characterized by the overproduction of VLDL, is a major driver of hypertriglyceridemia and contributes significantly to the development of atherosclerosis and cardiovascular disease. Conversely, inhibiting this process can lead to hepatic steatosis due to the retention of lipids within the hepatocyte.

Other names

VLDL assembly lipidsHepatocyte membrane lipidsLipoprotein lipidsVLDL core and surface lipids

Reduction of VLDL production through the inhibition of assembly-mediating proteins such as microsomal triglyceride transfer protein (MTP) or the reduction of apolipoprotein B-100 synthesis, thereby preventing the mobilization and loading of hepatocyte lipids into nascent VLDL particles.